Russia's COVID-19 vaccination rate reached around 129 administered doses per 100 population as of May 26, 2023. The rate of fully vaccinated residents was nearly 55.1 per 100 people. Russia’s COVID-19 vaccination rate was among the lowest in Europe.

COVID-19 vaccination in Russia

The mass vaccination against COVID-19 in Russia started at the beginning of 2021. As of May 2023, over 88 million Russians got at least one vaccine dose. Several regions, including the capital Moscow, required companies in specific industries to vaccinate at least 60 percent of their staff. Such sectors included healthcare, education, retail, and various services, among others. The restrictions were largely lifted in the spring and summer of 2022.

Attitude toward COVID-19 vaccination in Russia

When asked if they planned to get vaccinated against COVID-19, over one-quarter of Russians stated they would definitely or most probably do it, according to a survey from June 2021. Furthermore, nearly one-fifth of respondents reported being vaccinated already at that point. The most common motives to get vaccinated for Russians were to be able to travel without restrictions and not to worry about their health. The main reason behind vaccination hesitancy was a concern about the long-term consequences of COVID-19 vaccines.

Over 79.7 million Russians were fully vaccinated against COVID-19 as of May 26, 2023. In total, around 186.7 million doses of COVID-19 vaccines were administered in the country as of that date. The country's COVID-19 vaccination rate stood at 129 administered doses per 100 population.

View daily updates and historical trends for Russia Coronavirus Vaccination Rate: Any Dosage. Source: Our World in Data. Track economic data with YCharts …

The number of COVID-19 vaccination doses administered per 100 people in Russia rose to 129 as of Oct 27 2023. This dataset includes a chart with historical data for Russia Coronavirus Vaccination Rate.

Russia was to export 250 million doses of the coronavirus (COVID-19) vaccine Sputnik V to India, which was among the major planned producers of the vaccine. In total, Indian companies planned to produce at least 1,152 million doses of Sputnik V per year. Furthermore, Mexico ordered a total of 24 million doses of the vaccine. Sputnik V was authorized in more than 70 countries worldwide as of January 2022. Russia applied for the vaccine approval in the European Union in January 2021, while several EU countries approved its use earlier, such as Hungary or Slovakia.

Russia's first vaccine against COVID-19 In August 2020, Russia registered Sputnik V, the world’s first approved vaccine against COVID-19, which was developed at Gamaleya Research Institute in Moscow. After the third phase of clinical trials, the vaccine's effectiveness was measured at 91.6 percent. The mass vaccination in Russia started in January 2021. In December 2020, 30 percent of Russians would get vaccinated against COVID-19 with Sputnik V.
Is Sputnik V available abroad? In total, over 50 countries worldwide placed orders for Sputnik V from Russia. As of January 2021, The vaccine was used for vaccination in Russia, Belarus, Serbia. In October 2020, Russia applied for prequalification of Sputnik V at the WHO to speed up its availability worldwide. Other countries that would produce the vaccine, such as Brazil, China, India, or the Republic of Korea, would also sell it abroad. Among several countries surveyed in November 2020, the highest level of awareness about Sputnik V was recorded in Mexico.

In January 2023, 14 percent of Russians were ready to get vaccinated against the coronavirus (COVID-19). Over half percent of respondents did not want to receive a vaccine, while nearly one third had already received at least one dose. In the previous survey conducted in February 2022, the share of those who had already been vaccinated was higher, which could be explained by a different sample of respondents.

Actual value and historical data chart for Russia Immunization Measles Percent Of Children Ages 12 23 Months

As of January 18, 2023, Portugal had the highest COVID-19 vaccination rate in Europe having administered 272.78 doses per 100 people in the country, while Malta had administered 258.49 doses per 100. The UK was the first country in Europe to approve the Pfizer/BioNTech vaccine for widespread use and began inoculations on December 8, 2020, and so far have administered 224.04 doses per 100. At the latest data, Belgium had carried out 253.89 doses of vaccines per 100 population. Russia became the first country in the world to authorize a vaccine - named Sputnik V - for use in the fight against COVID-19 in August 2020. As of August 4, 2022, Russia had administered 127.3 doses per 100 people in the country.

The seven-day rate of cases across Europe shows an ongoing perspective of which countries are worst affected by the virus relative to their population. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.

Russia: Percent of one-year-old children with Hepatitis B immunization: The latest value from 2022 is 97 percent, unchanged from 97 percent in 2021. In comparison, the world average is 85 percent, based on data from 183 countries. Historically, the average for Russia from 2001 to 2022 is 94 percent. The minimum value, 43 percent, was reached in 2001 while the maximum of 98 percent was recorded in 2006.

Immunization, DPT (% of children ages 12-23 months) in Russia was reported at 97 % in 2024, according to the World Bank collection of development indicators, compiled from officially recognized sources. Russia - Immunization, DPT (% of children ages 12-23 months) - actual values, historical data, forecasts and projections were sourced from the World Bank on November of 2025.

Context

"Experts have warned that the race to produce a Covid-19 vaccine could make the pandemic worse in the long run. A weak or partially effective candidate could potentially result in people believing they are immune to the virus, resulting in higher rates of infection. That warning was recently voiced by Professor Richard Peto of Oxford University and an adviser to the World Health Organization, who said that the first vaccine would be distributed all over the world, even if it had low efficacy."

" Around the world, some publics are extremely cautious about a vaccine and remain reluctant to take one, with the vast majority of respondents citing potential side effects as a reason to avoid getting one."

"So where are people least concerned about taking a Covid-19 vaccine if it was available? Ipsos MORI found that 97 percent of people in China would take one, along with 88 percent in Brazil, 87 percent in India and 85 percent in the UK. Russia recently announcing that it was aiming to bring its Sputnik V vaccine to the market at some stage this month, despite the fact that it did not undergo large scale testing. Only 54 percent of Russians say they would take a vaccine if it was available, with the share of people in France also low at 59 percent. In both Germany and the United States, 67 percent of respondents say they would agree to take a vaccine, according to the research." https://www.statista.com/chart/22768/share-who-agree-they-would-take-a-covid-19-vaccine/

Content

This chart shows the share who agree/disagree they would take a Covid-19 vaccine if it was available. Source: Ipsos MORI

Acknowledgements

Source: Ipsos MORI Niall McCarthy, Data Journalist. https://www.statista.com/chart/22768/share-who-agree-they-would-take-a-covid-19-vaccine/

Photo by Markus Winkler on Unsplash

Inspiration

Covid-19.

In 2022, the immunisation of Hepatitis B in Russia did not change in comparison to the previous year. The immunisation remained at **** percent of children aged less than one year. Find more statistics on other topics about Russia with key insights such as share of children immunized against measles.

Turkmenistan led the ranking of countries in the Commonwealth of Independent States (CIS) by number of COVID-19 vaccination doses administered per 100 population, at over 210 as of September 4, 2022. Uzbekistan ranked second, with about 204 total vaccinations per 100 people. In Russia, nearly 54 people per 100 residents were fully vaccinated.

The Russian vaccine market rose rapidly to $593M in 2024, growing by 8.9% against the previous year. The market value increased at an average annual rate of +1.4% from 2012 to 2024; the trend pattern remained relatively stable, with somewhat noticeable fluctuations being observed in certain years. Vaccine consumption peaked in 2024 and is likely to see steady growth in the near future.

97.0 (%) in 2023. Child immunization measures the percentage of children ages 12-23 months who received vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.

Immunization, Pol3 (% of one-year-old children) in Russia was reported at 97 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. Russia - Immunization, Pol3 (% of one-year-old children) - actual values, historical data, forecasts and projections were sourced from the World Bank on November of 2025.

Four out of ten Russians did not get vaccinated against COVID-19 because they feared long-term health consequences, according to a survey from June 2021. Moreover, roughly one third were waiting for more people to get a vaccine when there would be more information about consequences of the vaccination. Side effects, such as fever or weakness, were named a reason behind vaccination hesitancy by 12 percent of respondents.

BackgroundEbola virus disease (EVD) is one of the most dangerous and lethal diseases affecting humans. There are several licensed vaccines against EVD, but it remains one of the priority diseases for research and development of effective vaccines.MethodsA double-blind randomized placebo-controlled trial was performed to evaluate safety and immunogenicity of rVSV- and rAd5-vectored vaccine GamEvac-Combi in healthy adults of both sexes between 18 and 60 years. Safety and immunogenicity were assessed during the observation period of 12 months. Immunogenicity was assessed with GP-specific ELISA, IFN-γ ELISA, and plaque pseudoneutralization assay.ResultsVaccinated participants showed marked GP-specific IFN-γ response at day 28 and neutralizing response at day 42 (GMT = 32.6, seroconversion rate 96.3%). GP-specific IgG antibody levels in vaccinated participants peaked at day 42 (GMT = 9345) and persisted for a year after vaccination (GMT = 650).ConclusionThe vaccine showed favorable safety profile and induced robust cell-mediated immune response and strong humoral immune response that lasts at least for a year from the start of vaccination.Clinical trial registrationClinicalTrials.gov, identifier NCT03072030; Pan African Clinical Trial Registry, identifier PACTR201702002053400.

Description of Data

Period: 01/03–30/03 Object: City or Region (842 cities — some data N/A, 84 regions) Target: inf_rate — infection rate, calculated as Log(infected_at_30.03 + 1) — Log( infected_at_15.03 + 1)

Explanatory Variables - population — number of citizens - density — population density (http://worldgeo.ru/russia/lists/?id=26) - lat — latitude - lng — longtitude - cleanness, public_services, neighbourhood, children_places, sport_and_outdoor, shops_and_malls, public_transport, security, life_costs — survey responses for life quality evaluation survey (https://www.domofond.ru/statya/polnyy_reyting_250_gorodov_rossii_po_kachestvu_zhizni/6764) - ivl_per_100k, ivl_number, ekmo_per_100k, ekmo_number — number of ventilators absolute and per 100k population, number of ECMO equipments — absolute and per 100k population. - infected_3003, died_3003, recovered_3003, sick_3003, infected_1503, died_1503, recovered_1503, sick_1503 — measure for calcularing infection_rate. We assume incubation period as two weeks and calculate log-transformed increment as proxy of reproduction rate (https://ru.wikipedia.org/wiki/%D0%A0%D0%B0%D1%81%D0%BF%D1%80%D0%BE%D1%81%D1%82%D1%80%D0%B0%D0%BD%D0%B5%D0%BD%D0%B8%D0%B5_COVID-19_%D0%B2_%D0%A0%D0%BE%D1%81%D1%81%D0%B8%D0%B8) - avg_temp_min, avg_temp_max, avg_temp_std, avg_temp_median, humidity_min, humidity_max, humidity_std, humidity_median, pressure_min, pressure_max, pressure_std, pressure_median, wind_speed_ms_min, wind_speed_ms_max, wind_speed_ms_std, wind_speed_ms_median — weather archive data for March 2020 from http://weatherarchive.ru/catalog1 - urban_50–54_years, urban_55–59_years, urban_60–64_years, urban_65–69_years, urban_70–74_years, urban_75–79_years, urban_80–84_years, urban_85–89_years, urban_90–94_years, rural_50–54_years, rural_55–59_years, rural_60–64_years, rural_65–69_years, rural_70–74_years, rural_75–79_years, rural_80–84_years, rural_85–89_years, rural_90–94_years — number of inhabitants by age groups and urban/rural areas, (http://showdata.gks.ru/, measure name — 23110000100030200007_Численность_постоянного_населения_России_по_возрасту_на_1_январ.) - work_ratio_15–72_years, work_ratio_55–64_years, work_ratio_15–24_years, work_ratio_15–64_years, work_ratio_25–54_years — percentage of people working by age groups (http://showdata.gks.ru/, measure name — 11242000300080200004_Уровень_занятости_по_полу_и_возрастным_группам) - num_patients_tubercul_1992 .. 2017 — number of tuberculosis patients by years (better or worse vaccination? vaccination data not available by regions, http://showdata.gks.ru/, measure name — 22420000100070200001_Численность_выявленных_пациентов_с_впервые_в_жизни_установленным_диагнозом_акт) - volume_serv_household_2017, volume_serv_chargeable_2017, volume_serv_transport_2017, volume_serv_post_2017, volume_serv_accommodation_2017, volume_serv_telecom_2017, volume_serv_others_2017, volume_serv_veterinary_2017, volume_serv_housing_2017, volume_serv_education_2017, volume_serv_medicine_2017, volume_serv_disabled_2017, volume_serv_culture_2017, volume_serv_sport_2017, volume_serv_hotels_2017, volume_serv_tourism_2017, volume_serv_sanatorium_2017 — volume of services by different types in RUB currency (http://showdata.gks.ru/, measure name — 21373000200010200001_Объем_платных_услуг_населению_с_2017_г_). Could be also useful as lower estimate of lost money due to lockdown. - num_phones_rural_2018, num_phones_urban_2018— number of phones by urban/rural area, (http://showdata.gks.ru/, measure name — 11111132100050200001_Число_телефонных_аппаратов_(включая_таксофоны). Could be also useful for evaluating possibility of contact tracing — at least at the level of availability of phones in risky areas. - bus_march_travel_18, bus_april_travel_18 — number of passenger kilometers * 1000 for buses in March/April 2018 (http://showdata.gks.ru/, measure name — Пассажирооборот автобусов по маршрутам регулярных перевозок (тысяча пассажиро-километров)) - epirank_avia, epirank_bus, epirank_train, epirank_avia_cat, epirank_bus_cat, epirank_train_cat — epirank indexes, calculated based on the following paper (prefix …cat — head/tail breaks, as described in the paper, daytime =0.55, d=1.0) https://www.researchgate.net/publication/332131602_EpiRank_Modeling_Bidirectional_Disease_Spread_in_Asymmetric_Commuting_Networks based on the following implementation: https://github.com/wcchin/EpiRank, based on the following data Origin-Destination data for Aviation, Trains and Buses from Tutu.ru (Thank you!): https://github.com/ods-ai-ml4sg/covid19-tutu whole_population, urban, rural — risky population from 65+group in the whole, and by urban/rural, http://showdata.gks.ru/)

COVID-19 in Russia was centered in the city of Moscow, which accounted for the highest number of cases, measuring at around 3.5 million as of June 4, 2023. It was followed by Saint Petersburg with more than 1.9 million cases. In total, over 22.9 million COVID-19 cases were recorded in Russia as of June 4, 2023.

COVID-19 in Moscow The city of Moscow was Russia’s region with the largest number of conducted COVID-19 tests. Moscow's self-isolation index during the lockdown indicated that most residents stayed home. With entertainment venues, restaurants and bars, and non-food shops closed, the subway traffic in the capital decreased by 85 percent compared to the previous year. Furthermore, car sharing services were suspended in the city due to risks of the COVID-19 contagion. Until the end of 2021, pensioners in Moscow could receive 10 thousand Russian rubles for getting vaccinated.

Self-isolation regime Due to the COVID-19 outbreak, Russia announced a non-working period until May 11, 2020. Its regions, or federal subjects, imposed additional quarantine measures to restrict movement of residents and transport during the shutdown. In most regions, the population could go outside only to the nearest grocery store, to walk a dog, or to see a doctor in emergency cases. Moscow authorities introduced digital passes, requiring Russians to register online before leaving home. Another lockdown was held from the end of October to the beginning of November. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.